C. difficile 2021 Focused Update - IDSA
https://www.idsociety.org/practice-guideline/clostridioides-difficile-2021-focused-update/
WEBJun 14, 2021 · Head-to-head trials of differing anti-CDI recurrence strategies using narrow-spectrum antibiotics that target C. difficile, restoration of the microbiome using biotherapeutics or FMT, or augmentation of the host immune response with agents such as bezlotoxumab given alone or in combination (eg, in combination with fidaxomicin) are …
DA: 37 PA: 81 MOZ Rank: 66